2015
DOI: 10.4067/s0034-98872015000100007
|View full text |Cite|
|
Sign up to set email alerts
|

Examen de detección de virus papiloma humano en el tamizaje de cáncer cervicouterino en un Servicio de Salud de Santiago, Chile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 14 publications
(9 reference statements)
0
2
0
1
Order By: Relevance
“…This is the first large-scale multicentre study evaluating the performance of cervical cytology and HPV in primary screening including more than 30,000 women across nine Latin American countries. 8 , 9 , 10 There is overwhelming evidence showing that HPV testing is more sensitive compared to cytology for detecting precancerous lesions, 14 , 15 and more effective at reducing cervical cancer. 6 , 16 , 17 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is the first large-scale multicentre study evaluating the performance of cervical cytology and HPV in primary screening including more than 30,000 women across nine Latin American countries. 8 , 9 , 10 There is overwhelming evidence showing that HPV testing is more sensitive compared to cytology for detecting precancerous lesions, 14 , 15 and more effective at reducing cervical cancer. 6 , 16 , 17 …”
Section: Discussionmentioning
confidence: 99%
“…7 Nevertheless, cytology continues to be widely used, particularly in Latin America where evidence on the performance of cytology in large screening populations remains limited. 8 , 9 , 10 …”
Section: Introductionmentioning
confidence: 99%
“…Los estudios de Jerónimo (11) , Terrazas (12) y Luciani (13) identificaron como prevalencia de positividad a lesiones cervicales por citología (Pap) un 4.2%, 1.7% y 1.6% respectivamente, en el presente estudio fue de 8.2%, la cual está asociado a la referencia de pacientes para la realización de pruebas de tamizaje en el Centro Oncomujer por su alta especialización en ginecología oncológica. Asimismo, que debido a su ubicación geográfica cercana al Instituto Nacional de Enfermedades Neoplásicas del Perú (INEN), muchos pacientes que no encuentran citas optan por realizarse los procedimientos diagnósticos en Centros oncológicos privados.…”
Section: Discussionunclassified